Eli Lilly partner TVM Capital raises $478M for their new life sciences fund, a 'substantial' oversubscription
A German-Canadian VC fund and high-profile Eli Lilly partner has nearly half a billion dollars in new cash to play with.
TVM Capital Life Science, based out of Munich and Montreal, announced the closing of its second and latest fund Tuesday with $478 million in hand. That total represents a “substantial” oversubscription, managing partner Stefan Fischer said, and a good 36.5% more than the $350 million initially expected.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.